<qa>  What is the goal of the study?The objective of the study is to determine the doses of Ro 205-2349 which, when compared to placebo, are efficacious, safe and tolerable in improving glycemic control in patients with type 2 diabetes. Doses of 2 to 5 mgday will be studied. 